Ali S, Dornhorst A. Diabetes in pregnancy: health risks and management. Postgrad Med J. 2011;87(1028):417–27.
Ballas J, Moore TR, Ramos GA. Management of diabetes in pregnancy. Curr Diab Rep. 2012;12:33–42.
Kaymak O, Iskender CT, Ustunyurt E, Yildiz Y, Doganay M, Danisman N. Retrospective evaluation of perinatal outcome in women with mild gestational hyperglycemia. J Obstet Gynaecol Res. 2011;37:986–91.
Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.PubMedCrossRefGoogle Scholar
Fraser RB, Waite SL, Wood KA, Martin KL. Impact of hyperglycemia on early embryo development and embryopathy: in vitro
experiments using a mouse model. Hum Reprod. 2007;22:3059–68.PubMedCrossRefGoogle Scholar
Bell R, Glinianaia SV, Tennant PW, Bilous RW, Rankin J. Peri–conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia. 2012;55(4):936–47.
Murphy HR, Roland JM, Skinner TC, Simmons D, Gurnell E, Morrish NJ, et al. Effectiveness of a regional pre-pregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care. 2010;33:2514–20.PubMedCrossRefGoogle Scholar
Hawthorne G. Maternal complications in diabetic pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25:77–90.
Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, Damm P, Mathiesen ER. Hypoglycemia during pregnancy in women with type 1 diabetes. Diabet Med. 2012;29:558–66.PubMedCrossRefGoogle Scholar
Rosenn BM, Miodovnik M, Holcberg G, Khoury JC, Siddiqi TA. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol. 1995;85:417–22.PubMedCrossRefGoogle Scholar
Kalhan SC, D’Angelo LJ, Savin SM, Adam PA. Glucose production in pregnant women at term gestation. Sources of glucose for human fetus. J Clin Invest. 1979;63:388–94.PubMedCrossRefGoogle Scholar
Baumann MU, Deborde S, Illsley NP. Placental glucose transfer and fetal growth. Endocrine. 2002;19:13–22.PubMedCrossRefGoogle Scholar
Herranz L, Pallardo LF, Hillman N, Martin-Vaquero P, Villarroel A, Fernandez A. Maternal third trimester hyperglycaemic excursions predict large-for-gestational-age infants in type 1 diabetic pregnancy. Diabetes Res Clin Pract. 2007;75:42–6.PubMedCrossRefGoogle Scholar
Kerssen A, de Valk HW, Visser GH. Increased second trimester maternal glucose levels are related to extremely large-for-gestational-age infants in women with type 1 diabetes. Diabetes Care. 2007;30:1069–74.PubMedCrossRefGoogle Scholar
Combs CA, Gunderson E, Kitzmiller JL, Gavin LA, Main EK. Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care. 1992;15:1251–7.PubMedCrossRefGoogle Scholar
Yessoufou A, Moutairou K. Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of “metabolic memory”. Exp Diabetes Res. 2011. doi:10.1155/2011/218598
Reece EA, Homko C, Miodovnik M, Langer O. A consensus report of the diabetes in pregnancy study group of North America conference, Little Rock, Arkansas, May 2002. J Matern Fetal Neonatal Med. 2002;12:362–4.PubMedCrossRefGoogle Scholar
Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care. 2005;28:1231–9.PubMedCrossRefGoogle Scholar
Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, et al. Improvement in glycemic excursions with a transcutaneous, real–time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006;29:44–50.PubMedCrossRefGoogle Scholar
McCall AL. Insulin therapy and hypoglycemia. Endocrinol Metab Clin North Am. 2012;41:57–87.
Yardley JE, Kenny GP, Perkins BA, Riddell MC, Malcolm Boulay J, et al. Effects of performing resistance exercise before vs after aerobic exercise on glycemia in type 1 diabetes. Diabetes Care. 2012;35:669–75.
Riddell M, Perkins BA. Exercise and glucose metabolism in persons with diabetes mellitus: perspectives on the role for continuous glucose monitoring. J Diabetes Sci Technol. 2009;3:914–23.PubMedGoogle Scholar
Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2012. doi:10.1002/14651858.CD008101.pub2
Szypowska A, Ramotowska A, Dzygalo K, Golicki D. Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials. Eur J Endocrinol. 2012;166:567–74.
Thorsell A, Gordon M, Jovanovic L. Continuous glucose monitoring: a stepping stone in the journey towards a cure for diabetes. J Matern Fetal Neonatal Med. 2004;15(1):15–25.PubMedCrossRefGoogle Scholar
• Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O. Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women. Am J Obstet Gynecol. 2004;191:949–53. This study provides the first insights into CGM glucose profiles in obese pregnancies
Buhling KJ, Winkel T, Wolf C, Kurzidim B, Mahmoudi Wohlfarth MK, et al. Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS). J Perinat Med. 2005;33:125–31.PubMedCrossRefGoogle Scholar
• Siegmund T, Rad NT, Ritterath C, Siebert G, Henrich W, Buhling KJ. Longitudinal changes in the continuous glucose profile measured by the CGMS in healthy pregnant women and determination of cut-off values. Eur J Obstet Gynecol Reprod Biol. 2008;139:46–52. This study provides longitudinal CGM profiles during pregnancy and at 6 weeks postpartum
Mazze R, Yogev Y, Langer O. Measuring glucose exposure and variability using continuous glucose monitoring in normal and abnormal glucose metabolism in pregnancy. J Matern Fetal Neonatal Med. 2012;25:1171–5.PubMedCrossRefGoogle Scholar
Hernandez TL, Friedman JE, Van Pelt RE, Barbour LA. Patterns of glycaemia in normal pregnancy: should the current therapeutic targets be challenged? Diabetes Care. 2011;34:1660–8.PubMedCrossRefGoogle Scholar
Ryan EA. Comment on: Hernandez et al. Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged? Diabetes Care. 2011;34:1660–8. Diabetes Care. 2011;34:e174; author’s reply e175.CrossRefGoogle Scholar
•• Harmon KA, Gerard L, Jensen DR, Kealey EH, Hernandez TL, Reece MS, et al. Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: metabolic determinants of fetal growth. Diabetes Care. 2011;34:2198–204. This study provided further insights into the CGM profiles of healthy and obese pregnant women with carefully controlled dietary and gestational age conditions.
Ng SK, Olog A, Spinks AB, Cameron CM, Searle J, McClure RJ. Risk factors and obstetric complications of large for gestational age births with adjustments for community effects: results from a new cohort study. BMC Public Health. 2010;10:460.
Jolly MC, Sebire NJ, Harris JP, Regan L, Robinson S. Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol. 2003;111:9–14.PubMedCrossRefGoogle Scholar
Ben-Haroush A, Yogev Y, Chen R, Rosenn B, Hod M, Langer O. The postprandial glucose profile in the diabetic pregnancy. Am J Obstet Gynecol. 2004;191:576–81.PubMedCrossRefGoogle Scholar
Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, et al. Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy. Diabetologia. 2012;55:282–93.
Chen R, Yogev Y, Ben-Haroush A, Jovanovic L, Hod M, Phillip M. Continuous glucose monitoring for the evaluation and improved control of gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2003;14:256–60.PubMedCrossRefGoogle Scholar
Buhling KJ, Kurzidim B, Wolf C, Wohlfarth K, Mahmoudi M, Wascher C, et al. Introductory experience with the continuous glucose monitoring system (CGMS; Medtronic minimed) in detecting hyperglycaemia by comparing the self-monitoring of blood glucose (SMBG) in non-pregnant women and in pregnant women with impaired glucose tolerance and gestational diabetes. Exp Clin Endocrinol Diabetes. 2004;112:556–60.PubMedCrossRefGoogle Scholar
Cypryk K, Pertynska-Marczewska M, Szymczak W, Wilcynski J, Lewinski A. Evaluation of metabolic control in women with gestational diabetes mellitus by the continuous glucose monitoring system: a pilot study. Endocr Pract. 2006;12:245–50.PubMedGoogle Scholar
Kestila KK, Ekblad UU, Ronnemaa T. Continuous glucose monitoring vs self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. Diabetes Res Clin Pract. 2007;77:174–9.PubMedCrossRefGoogle Scholar
Yogev Y, Chen R, Ben-Haroush A, Phillip M, Jovanovic L, Hod M. Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstet Gynecol. 2003;101:633–8.PubMedCrossRefGoogle Scholar
Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study group’s recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82.
Schneider S, Bock C, Wetzel M, Maul H, Loerbroks A. The prevalence of gestational diabetes in advanced economies. J Perinat Med. 2012;0(0):1–10.
Radder JK, van Roosmalen J. HbA1c in healthy, pregnant women. Neth J Med. 2005;63:256–9.PubMedGoogle Scholar
Kerssen A, de Valk HW, Visser GH. Day-to-day glucose variability during pregnancy in women with type 1 diabetes mellitus: glucose profiles measured with the continuous glucose monitoring system. BJOG. 2004;111:919–24.PubMedCrossRefGoogle Scholar
Kerssen A, de Valk HW, Visser GH. Do HbA(1)c levels and the self-monitoring of blood glucose levels adequately reflect glycaemic control during pregnancy in women with type 1 diabetes mellitus? Diabetologia. 2006;49:25–8.PubMedCrossRefGoogle Scholar
Kerssen A, de Valk HW, Visser GH. Forty-eight-hour first-trimester glucose profiles in women with type 1 diabetes mellitus: a report of three cases of congenital malformation. Prenat Diagn. 2006;26:123–7.PubMedCrossRefGoogle Scholar
Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke W. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care. 1998;21:1870–5.PubMedCrossRefGoogle Scholar
Porter H, Lookinland S, Belfort MA. Evaluation of a new real-time blood continuous glucose monitoring system in pregnant women without gestational diabetes. A pilot study. J Perinat Neonatal Nurs. 2004;18:93–102.PubMedGoogle Scholar
Dalfra MG, Sartore G, Di Cianni G, Mello G, Lencioni C, Ottanelli S, et al. Glucose variability in diabetic pregnancy. Diabetes Technol Ther. 2011;13:853–9.
Zisser HC, Biersmith MA, Jovanovic LB, Yogev Y, Hod M, Kovatchev BP. Fetal risk assessment in pregnancies complicated by diabetes mellitus. J Diabetes Sci Technol. 2010;4(6):1368–73.
• Murphy HR, Rayman G, Duffield K, Lewis KS, Kelly S, Johal B, et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care. 2007;30:2785–91. These are the first detailed CGM insights into type 1 and type 2 diabetes pregnancy
Stenninger E, Lindqvist A, Aman J, Ostlund I, Schvarcz E. Continuous subcutaneous glucose monitoring system in diabetic mothers during labor and postnatal glucose adaptation of their infants. Diabet Med. 2008;25:450–4.PubMedCrossRefGoogle Scholar
•• Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomized clinical trial. BMJ. 2008;337:a1680. This is the only randomized intervention study of CGM in pregestational diabetes
Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359:1464–76.PubMedCrossRefGoogle Scholar
Anderson J, Attvall S, Sternemalm L, Pivodic A, Fahlen M, Hanas R, et al. Effect on glycemic control by short- and long-term use of continuous glucose monitoring in clinical practice. J Diabetes Sci Technol. 2011;5(6):1472–9.
Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM. Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care. 2012;35:32–8.
Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomized controlled trials using individual patient data. BMJ. 2011;343:d3805.PubMedCrossRefGoogle Scholar
Holmes VA, Young IS, Patterson CC, Pearson DW, Walker JD, Maresh MJ, et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care. 2011;34:1683–8.PubMedCrossRefGoogle Scholar
McLachlan K, Jenkins A, O’Neal D. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy. Aust N Z J Obstet Gynaecol. 2007;47:186–90.PubMedCrossRefGoogle Scholar
Secher AL, Madsen AB, Ringholm L, Barfred C, Stage E, Andersen HU, et al. Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes. Diabet Med. 2012;29:272–7.
Murphy HR, Kumareswaran K, Elleri D, Allen JM, Caldwell K, Biagioni M, et al. Safety and efficacy of 24-hour closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Care. 2011;34:2527–9.PubMedCrossRefGoogle Scholar
Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, et al. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care. 2011;34:406–11.PubMedCrossRefGoogle Scholar